Cargando…

Characterization of COVID-19 vaccine clinical trial discussions on the social question-and-answer site Quora

INTRODUCTION: Throughout the COVID-19 pandemic, underserved populations, such as racial and ethnic minorities, were disproportionately impacted by illness, hospitalization, and death. Equity in clinical trials means that the participants in clinical trials represent the people who are most likely to...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Qing, McMann, Tiana J., Li, Jiawei, Wenzel, Christine, Mackey, Tim K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696860/
http://dx.doi.org/10.1186/s13063-023-07837-5
_version_ 1785154661440815104
author Xu, Qing
McMann, Tiana J.
Li, Jiawei
Wenzel, Christine
Mackey, Tim K.
author_facet Xu, Qing
McMann, Tiana J.
Li, Jiawei
Wenzel, Christine
Mackey, Tim K.
author_sort Xu, Qing
collection PubMed
description INTRODUCTION: Throughout the COVID-19 pandemic, underserved populations, such as racial and ethnic minorities, were disproportionately impacted by illness, hospitalization, and death. Equity in clinical trials means that the participants in clinical trials represent the people who are most likely to have the health condition and need the treatment that the trial is testing. Infodemiology approaches examining user conversations on social media platforms have the potential to elucidate specific barriers and challenges related to clinical trial participation, including among racial and ethnic minority populations. MATERIALS AND METHODS: The study retrospectively collected and analyzed user question and answer posts from Quora in October 2021 using an inductive content coding approach. We also examined user’s publicly available profile metadata to identify racial and ethnic minority users to capture their experiences, attitudes, topics, and discussions of barriers to COVID-19 vaccine trials. RESULTS: A total of 1073 questions and 7479 answers were collected. A total of 763 questions and 2548 answers were identified as related to COVID-19 vaccine clinical trials. The majority of these online interactions focused on asking questions and sharing knowledge and opinions about COVID-19 vaccine trials, including major topics related to: (a) interpreting whether clinical trial results could be trusted; (b) questions about vaccine efficacy and safety; (c) understanding trial design, regulatory considerations, and vaccine platforms; and (d) questions about trial enrollment, length, and adequate representation. Additionally, four major barriers discussed included: (i) disagreement from users regarding whether clinical trials require representation from different racial and ethnic minorities; (ii) concerns regarding the safety of trials when participating; (iii) lack of knowledge on how to participate in a trial; and (iv) questions of whether participants could withdraw from a trial to access an approved COVID-19 vaccine. CONCLUSIONS: Our study found active user discussions related to COVID-19 vaccine clinical trials on Quora, including those specific to minority health topics and those posted by a smaller group of self-identified racial and ethnic minority online users. Results from this study can help identify barriers to participation among the general public and underrepresented groups while also supporting the design of future outreach strategies to help with recruitment and inclusive trial participation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13063-023-07837-5.
format Online
Article
Text
id pubmed-10696860
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106968602023-12-06 Characterization of COVID-19 vaccine clinical trial discussions on the social question-and-answer site Quora Xu, Qing McMann, Tiana J. Li, Jiawei Wenzel, Christine Mackey, Tim K. Trials Research INTRODUCTION: Throughout the COVID-19 pandemic, underserved populations, such as racial and ethnic minorities, were disproportionately impacted by illness, hospitalization, and death. Equity in clinical trials means that the participants in clinical trials represent the people who are most likely to have the health condition and need the treatment that the trial is testing. Infodemiology approaches examining user conversations on social media platforms have the potential to elucidate specific barriers and challenges related to clinical trial participation, including among racial and ethnic minority populations. MATERIALS AND METHODS: The study retrospectively collected and analyzed user question and answer posts from Quora in October 2021 using an inductive content coding approach. We also examined user’s publicly available profile metadata to identify racial and ethnic minority users to capture their experiences, attitudes, topics, and discussions of barriers to COVID-19 vaccine trials. RESULTS: A total of 1073 questions and 7479 answers were collected. A total of 763 questions and 2548 answers were identified as related to COVID-19 vaccine clinical trials. The majority of these online interactions focused on asking questions and sharing knowledge and opinions about COVID-19 vaccine trials, including major topics related to: (a) interpreting whether clinical trial results could be trusted; (b) questions about vaccine efficacy and safety; (c) understanding trial design, regulatory considerations, and vaccine platforms; and (d) questions about trial enrollment, length, and adequate representation. Additionally, four major barriers discussed included: (i) disagreement from users regarding whether clinical trials require representation from different racial and ethnic minorities; (ii) concerns regarding the safety of trials when participating; (iii) lack of knowledge on how to participate in a trial; and (iv) questions of whether participants could withdraw from a trial to access an approved COVID-19 vaccine. CONCLUSIONS: Our study found active user discussions related to COVID-19 vaccine clinical trials on Quora, including those specific to minority health topics and those posted by a smaller group of self-identified racial and ethnic minority online users. Results from this study can help identify barriers to participation among the general public and underrepresented groups while also supporting the design of future outreach strategies to help with recruitment and inclusive trial participation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13063-023-07837-5. BioMed Central 2023-12-05 /pmc/articles/PMC10696860/ http://dx.doi.org/10.1186/s13063-023-07837-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Xu, Qing
McMann, Tiana J.
Li, Jiawei
Wenzel, Christine
Mackey, Tim K.
Characterization of COVID-19 vaccine clinical trial discussions on the social question-and-answer site Quora
title Characterization of COVID-19 vaccine clinical trial discussions on the social question-and-answer site Quora
title_full Characterization of COVID-19 vaccine clinical trial discussions on the social question-and-answer site Quora
title_fullStr Characterization of COVID-19 vaccine clinical trial discussions on the social question-and-answer site Quora
title_full_unstemmed Characterization of COVID-19 vaccine clinical trial discussions on the social question-and-answer site Quora
title_short Characterization of COVID-19 vaccine clinical trial discussions on the social question-and-answer site Quora
title_sort characterization of covid-19 vaccine clinical trial discussions on the social question-and-answer site quora
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696860/
http://dx.doi.org/10.1186/s13063-023-07837-5
work_keys_str_mv AT xuqing characterizationofcovid19vaccineclinicaltrialdiscussionsonthesocialquestionandanswersitequora
AT mcmanntianaj characterizationofcovid19vaccineclinicaltrialdiscussionsonthesocialquestionandanswersitequora
AT lijiawei characterizationofcovid19vaccineclinicaltrialdiscussionsonthesocialquestionandanswersitequora
AT wenzelchristine characterizationofcovid19vaccineclinicaltrialdiscussionsonthesocialquestionandanswersitequora
AT mackeytimk characterizationofcovid19vaccineclinicaltrialdiscussionsonthesocialquestionandanswersitequora